<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to the scheduled activities regarding the scientific project, the hosting institution, BfR, provided an additional training curriculum, and also enabled the fellow to participate in some other activities that played an important role in developing the general knowledge on risk assessment. For example, the fellow attended the 5th German Pharm‐Tox Summit 2020 in March 2020 and presented results of her project as a conference poster on that occasion (Raclariu‐Manolica et al., 
 <xref rid="efs2e181112-bib-0021" ref-type="ref">2020</xref>). This also provided the opportunity for her to interact with a broad scientific community from academia as well as from regulatory institutions.
</p>
